Loading...
Header Logo
Keywords
Last Name
Institution

Dome, Jeffrey

TitleVP CCBD
InstitutionChildrens National Medical Center
DepartmentHem/onc
Address111 Michigan Ave NW
Washington DC 20010
Phone(202) 4765648
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Ann Surg. 2017 Apr; 265(4):835-840. PMID: 27811504.
      View in: PubMed
    2. Gooskens SL, Houwing ME, Vujanic GM, Dome JS, Diertens T, Coulomb-l'Herminé A, Godzinski J, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM. Congenital mesoblastic nephroma 50 years after its recognition: A narrative review. Pediatr Blood Cancer. 2017 Jan 26. PMID: 28124468.
      View in: PubMed
    3. Venkatramani R, Chi YY, Coppes MJ, Malogolowkin M, Kalapurakal JA, Tian J, Dome JS. Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials. Pediatr Blood Cancer. 2017 Jan 18. PMID: 28097788.
      View in: PubMed
    4. Interiano RB, McCarville MB, Santos ND, Mao S, Wu J, Dome JS, Kieran K, Williams MA, Brennan RC, Krasin MJ, Green DM, Davidoff AM. Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor. J Pediatr Surg. 2017 Jan; 52(1):98-103. PMID: 27856008.
      View in: PubMed
    5. Ooms AH, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Ma Y, Zong Z, Mungall AJ, Moore RA, Marra MA, Huff V, Dome JS, Chi YY, Tian J, Geller JI, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Walz AL, van den Heuvel-Eibrink MM, de Krijger RR, Ross N, Gastier-Foster JM, Perlman EJ. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Nov 15; 22(22):5582-5591. PMID: 27702824.
      View in: PubMed
    6. Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol. 2016 Sep 10; 34(26):3189-94. PMID: 27400937; PMCID: PMC5012705 [Available on 09/10/17].
    7. Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E. Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 Nov; 63(11):1905-10. PMID: 27229358.
      View in: PubMed
    8. Perlman EJ, Gadd S, Arold ST, Radhakrishnan A, Gerhard DS, Jennings L, Huff V, Guidry Auvil JM, Davidsen TM, Dome JS, Meerzaman D, Hsu CH, Nguyen C, Anderson J, Ma Y, Mungall AJ, Moore RA, Marra MA, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Gastier-Foster JM, Ross N, Smith MA. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. Nat Commun. 2015 Dec 04; 6:10013. PMID: 26635203; PMCID: PMC4686660.
    9. Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol. 2016 Feb; 48:81-7. PMID: 26772403; PMCID: PMC4979561 [Available on 02/01/17].
    10. Davidoff AM, Interiano RB, Wynn L, Delos Santos N, Dome JS, Green DM, Brennan RC, McCarville MB, Krasin MJ, Kieran K, Williams MA. Overall Survival and Renal Function of Patients With Synchronous Bilateral Wilms Tumor Undergoing Surgery at a Single Institution. Ann Surg. 2015 Oct; 262(4):570-6. PMID: 26366536.
      View in: PubMed
    11. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):2999-3007. PMID: 26304882; PMCID: PMC4567702 [Available on 09/20/16].
    12. Hu Y, Bobb D, He J, Hill DA, Dome JS. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Cancer Biol Ther. 2015; 16(6):949-57. PMID: 25920748; PMCID: PMC4622625.
    13. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64. PMID: 25845370; PMCID: PMC4588054.
    14. Dean JB, Dome JS. Reply to Wilms tumor and breast cancer. Cancer. 2015 Jun 15; 121(12):2100-1. PMID: 25712509.
      View in: PubMed
    15. Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Bowlby R, Brooks D, Ma Y, Mungall AJ, Moore RA, Schein J, Marra MA, Huff V, Dome JS, Chi YY, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Jafari N, Ross N, Gastier-Foster JM, Perlman EJ. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 2015 Feb 09; 27(2):286-97. PMID: 25670082; PMCID: PMC4800737.
    16. Ortiz MV, Rossi CT, Hill DA, Guzzetta PC, Qureshi F, Dome JS. Inflammatory myofibroblastic tumor as a second neoplasm after Wilms tumor. Pediatr Blood Cancer. 2015 Jun; 62(6):1075-7. PMID: 25504840.
      View in: PubMed
    17. Dean JB, Dome JS. Breast cancer in Wilms tumor survivors: new insights into primary and secondary prevention. Cancer. 2014 Dec 01; 120(23):3598-601. PMID: 25347942.
      View in: PubMed
    18. Maschietto M, Williams RD, Chagtai T, Popov SD, Sebire NJ, Vujanic G, Perlman E, Anderson JR, Grundy P, Dome JS, Pritchard-Jones K. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia. PLoS One. 2014; 9(10):e109924. PMID: 25313908; PMCID: PMC4196953.
    19. Hu Y, Bobb D, Lu Y, He J, Dome JS. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor. Cancer Genet. 2014 Sep; 207(9):403-11. PMID: 25441685.
      View in: PubMed
    20. Servaes S, Khanna G, Naranjo A, Geller JI, Ehrlich PF, Gow KW, Perlman EJ, Dome JS, Gratias E, Mullen EA. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol. 2015 Feb; 45(2):166-72. PMID: 25135711; PMCID: PMC4337797.
    21. Ferrer FA, Herbst KW, Fernandez CV, Khanna G, Dome JS, Naranjo A, Mullen EA, Geller JI, Gratias EJ, Shamberger R, Ritchey M, Ehrlich PF. Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement. J Pediatr Urol. 2014 Oct; 10(5):969-73. PMID: 24863984; PMCID: PMC4339089.
    22. Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, Cajaiba MM, Perlman EJ, A Schultz K, Cathro HP, Legallo RD, LaFortune KA, Chikwava KR, Faria P, Geller JI, Dome JS, Mullen EA, Gratias EJ, Dehner LP, Hill DA. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 2014 Sep; 27(9):1267-80. PMID: 24481001; PMCID: PMC4117822.
    23. Dome JS, Perlman EJ, Graf N. Risk stratification for wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014; 215-23. PMID: 24857079.
      View in: PubMed
    24. Kieran K, Williams MA, McGregor LM, Dome JS, Krasin MJ, Davidoff AM. Repeat nephron-sparing surgery for children with bilateral Wilms tumor. J Pediatr Surg. 2014 Jan; 49(1):149-53. PMID: 24439600.
      View in: PubMed
    25. Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. Pediatr Blood Cancer. 2014 Feb; 61(2):198-205. PMID: 24115727; PMCID: PMC3955491.
    26. Gratias EJ, Jennings LJ, Anderson JR, Dome JS, Grundy P, Perlman EJ. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer. 2013 Nov 01; 119(21):3887-94. PMID: 23983061; PMCID: PMC4362793.
    27. Green DM, Breslow NE, D'Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB, Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PR, Kalapurakal JA. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014 Jan; 61(1):134-9. PMID: 24038736; PMCID: PMC3933291.
    28. Kieran K, Williams MA, Dome JS, McGregor LM, Krasin MJ, Davidoff AM. Margin status and tumor recurrence after nephron-sparing surgery for bilateral Wilms tumor. J Pediatr Surg. 2013 Jul; 48(7):1481-5. PMID: 23895958.
      View in: PubMed
    29. Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green DM, Davidoff AM. Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children's Oncology Group. J Pediatr Surg. 2013 Jul; 48(7):1598-603. PMID: 23895979.
      View in: PubMed
    30. Malogolowkin M, Spreafico F, Dome JS, van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM, Bergeron C, de Kraker J, Graf N. Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer. 2013 Oct; 60(10):1612-5. PMID: 23737480.
      View in: PubMed
    31. Ferrer FA, Rosen N, Herbst K, Fernandez CV, Khanna G, Dome JS, Mullen E, Gow KW, Barnhart DC, Shamberger RC, Ritchey M, Ehrlich P. Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group. J Urol. 2013 Nov; 190(5):1846-51. PMID: 23727411.
      View in: PubMed
    32. Ehrlich PF, Anderson JR, Ritchey ML, Dome JS, Green DM, Grundy PE, Perlman EJ, Kalapurakal JA, Breslow NE, Shamberger RC. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. J Clin Oncol. 2013 Mar 20; 31(9):1196-201. PMID: 23382471; PMCID: PMC3595426.
    33. Gow KW, Barnhart DC, Hamilton TE, Kandel JJ, Chen MK, Ferrer FA, Price MR, Mullen EA, Geller JI, Gratias EJ, Rosen N, Khanna G, Naranjo A, Ritchey ML, Grundy PE, Dome JS, Ehrlich PF. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg. 2013 Jan; 48(1):34-8. PMID: 23331790; PMCID: PMC4556229.
    34. Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, Buddavarapu KC, Broaddus R, Hornsby P, Tomlinson G, Dome J, Vadlamudi RK, Pertsemlidis A, Chen Y, Rao MK. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One. 2012; 7(12):e52397. PMID: 23285024; PMCID: PMC3528651.
    35. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix DB, Ehrlich PF, Khanna G, Malogolowkin MH, Anderson JR, Naranjo A, Perlman EJ. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):994-1000. PMID: 23255438; PMCID: PMC4127041.
    36. Khanna G, Naranjo A, Hoffer F, Mullen E, Geller J, Gratias EJ, Ehrlich PF, Perlman EJ, Rosen N, Grundy P, Dome JS. Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. Radiology. 2013 Feb; 266(2):610-7. PMID: 23192775; PMCID: PMC3558872.
    37. Sadak KT, Ritchey ML, Dome JS. Paediatric genitourinary cancers and late effects of treatment. Nat Rev Urol. 2013 Jan; 10(1):15-25. PMID: 23183945.
      View in: PubMed
    38. Ha TC, Spreafico F, Graf N, Dallorso S, Dome JS, Malogolowkin M, Furtwängler R, Hale JP, Moroz V, Machin D, Pritchard-Jones K. An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. Eur J Cancer. 2013 Jan; 49(1):194-210. PMID: 22959164.
      View in: PubMed
    39. Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L, Green DM, Beckwith JB, Perlman EJ. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia. 2012 Aug; 14(8):742-56. PMID: 22952427; PMCID: PMC3431181.
    40. Kalapurakal JA, Perlman EJ, Seibel NL, Ritchey M, Dome JS, Grundy PE. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):428-31. PMID: 22658515.
      View in: PubMed
    41. Gooskens SL, Furtwängler R, Vujanic GM, Dome JS, Graf N, van den Heuvel-Eibrink MM. Clear cell sarcoma of the kidney: a review. Eur J Cancer. 2012 Sep; 48(14):2219-26. PMID: 22579455.
      View in: PubMed
    42. Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, Seal S, Munoz-Xicola RM, Hanks S, Slade I, Zachariou A, Warren-Perry M, Ruark E, Gerrard M, Hale J, Hewitt M, Kohler J, Lane S, Levitt G, Madi M, Morland B, Neefjes V, Nicholson J, Picton S, Pizer B, Ronghe M, Stevens M, Traunecker H, Stiller CA, Pritchard-Jones K, Dome J, Grundy P, Rahman N. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet. 2012 Apr 29; 44(6):681-4. PMID: 22544364; PMCID: PMC3400150.
    43. Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green DM, Davidoff AM. Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5. J Pediatr Surg. 2012 Apr; 47(4):700-6. PMID: 22498384; PMCID: PMC3976547.
    44. Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, Dome JS. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Oct; 59(4):631-5. PMID: 22422736; PMCID: PMC3397278.
    45. Khozeimeh N, Sinha P, Dome JS, Guzzetta PC. Strategy for management of retroperitoneal tumors with caval tumor thrombus. J Pediatr Surg. 2011 Nov; 46(11):2065-70. PMID: 22075334.
      View in: PubMed
    46. Fernandez CV, Li N, Mullen EA, Grundy PE, Perman EJ, Shamberger RC, Ehrlich PF, Dome JS. Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2011 Oct; 33(7):521-3. PMID: 21941145; PMCID: PMC3496383.
    47. Drissi R, Wu J, Hu Y, Bockhold C, Dome JS. Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells. Cancer Prev Res (Phila). 2011 Dec; 4(12):1973-81. PMID: 21930799; PMCID: PMC3232288.
    48. Williams RD, Al-Saadi R, Natrajan R, Mackay A, Chagtai T, Little S, Hing SN, Fenwick K, Ashworth A, Grundy P, Anderson JR, Dome JS, Perlman EJ, Jones C, Pritchard-Jones K. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer. 2011 Dec; 50(12):982-95. PMID: 21882282.
      View in: PubMed
    49. Segers H, van den Heuvel-Eibrink MM, Pritchard-Jones K, Coppes MJ, Aitchison M, Bergeron C, de Camargo B, Dome JS, Grundy P, Gatta G, Graf N, Grundy P, Kalapurakal JA, de Kraker J, Perlman EJ, Reinhard H, Spreafico F, Vujanic G, Warwick AB. Management of adults with Wilms' tumor: recommendations based on international consensus. Expert Rev Anticancer Ther. 2011 Jul; 11(7):1105-13. PMID: 21806333.
      View in: PubMed
    50. Khanna G, Rosen N, Anderson JR, Ehrlich PF, Dome JS, Gow KW, Perlman E, Barnhart D, Karolczuk K, Grundy P. Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Apr; 58(4):551-5. PMID: 21674767; PMCID: PMC3175263.
    51. Perlman EJ, Grundy PE, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC, Ruteshouser EC, Huff V. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. J Clin Oncol. 2011 Feb 20; 29(6):698-703. PMID: 21189373; PMCID: PMC3056654.
    52. Kalapurakal JA, Green DM, Haase G, Anderson JR, Dome JS, Grundy PE. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. Int J Radiat Oncol Biol Phys. 2010 Jun 01; 77(2):554-8. PMID: 20457352; PMCID: PMC2868597.
    53. Moinul Hossain AK, Shulkin BL, Gelfand MJ, Bashir H, Daw NC, Sharp SE, Nadel HR, Dome JS. FDG positron emission tomography/computed tomography studies of Wilms' tumor. Eur J Nucl Med Mol Imaging. 2010 Jul; 37(7):1300-8. PMID: 20204356; PMCID: PMC4720968.
    54. Coppes MJ, Ware RE, Dome JS. Preface. Developments in pediatric oncology and hematology. Hematol Oncol Clin North Am. 2010 Feb; 24(1):xiii-xv. PMID: 20113892.
      View in: PubMed
    55. Spreafico F, Pritchard Jones K, Malogolowkin MH, Bergeron C, Hale J, de Kraker J, Dallorso S, Acha T, de Camargo B, Dome JS, Graf N. Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther. 2009 Dec; 9(12):1807-15. PMID: 19954292.
      View in: PubMed
    56. Sredni ST, Gadd S, Huang CC, Breslow N, Grundy P, Green DM, Dome JS, Shamberger RC, Beckwith JB, Perlman EJ. Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clin Cancer Res. 2009 Nov 15; 15(22):6800-9. PMID: 19903788; PMCID: PMC2782600.
    57. Ehrlich PF, Ferrer FA, Ritchey ML, Anderson JR, Green DM, Grundy PE, Dome JS, Kalapurakal JA, Perlman EJ, Shamberger RC. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group. Ann Surg. 2009 Oct; 250(4):642-8. PMID: 19730241; PMCID: PMC3302661.
    58. Drake KM, Ruteshouser EC, Natrajan R, Harbor P, Wegert J, Gessler M, Pritchard-Jones K, Grundy P, Dome J, Huff V, Jones C, Aldred MA. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562. Clin Cancer Res. 2009 Oct 01; 15(19):5985-92. PMID: 19789318; PMCID: PMC2756455.
    59. Geller JI, Dome JS. Retroperitoneal lymph node dissection for pediatric renal cell carcinoma. Pediatr Blood Cancer. 2009 Mar; 52(3):430. PMID: 19003909.
      View in: PubMed
    60. Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res. 2009 Mar 01; 15(5):1770-8. PMID: 19208794; PMCID: PMC2847352.
    61. Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM. Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Feb; 52(2):254-8. PMID: 18989885; PMCID: PMC2744809.
    62. Freeman SS, Allen SW, Ganti R, Wu J, Ma J, Su X, Neale G, Dome JS, Daw NC, Khoury JD. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Cancer. 2008 Sep 15; 113(6):1453-61. PMID: 18704985; PMCID: PMC3529469.
    63. Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res. 2008 Jul 15; 14(14):4572-83. PMID: 18628472; PMCID: PMC4209898.
    64. Davidoff AM, Giel DW, Jones DP, Jenkins JJ, Krasin MJ, Hoffer FA, Williams MA, Dome JS. The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006. Cancer. 2008 May 01; 112(9):2060-70. PMID: 18361398.
      View in: PubMed
    65. Coppes MJ, Dome JS. Pediatric Clinics of North America: pediatric oncology. Preface. Pediatr Clin North Am. 2008 Feb; 55(1):xv-xvi. PMID: 18242311.
      View in: PubMed
    66. Radulescu VC, Gerrard M, Moertel C, Grundy PE, Mathias L, Feusner J, Diller L, Dome JS. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis. Pediatr Blood Cancer. 2008 Feb; 50(2):246-9. PMID: 17226850.
      View in: PubMed
    67. Gratias EJ, Dome JS. Current and emerging chemotherapy treatment strategies for Wilms tumor in North America. Paediatr Drugs. 2008; 10(2):115-24. PMID: 18345721.
      View in: PubMed
    68. Gupta H, Conrad J, Khoury JD, McGregor LM, Krasin MJ, Dome JS, Santana VM, Davidoff AM. Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer. 2007 Dec; 49(7):906-8. PMID: 17417797.
      View in: PubMed
    69. Kaste SC, Dome JS, Babyn PS, Graf NM, Grundy P, Godzinski J, Levitt GA, Jenkinson H. Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol. 2008 Jan; 38(1):2-17. PMID: 18026723.
      View in: PubMed
    70. Giel DW, Williams MA, Jones DP, Davidoff AM, Dome JS. Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor. J Urol. 2007 Oct; 178(4 Pt 2):1786-9; discussion 1789-90. PMID: 17707428.
      View in: PubMed
    71. Metzger ML, Stewart CF, Freeman BB, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol. 2007 Jul 20; 25(21):3130-6. PMID: 17634492.
      View in: PubMed
    72. Levashova ZB, Sharma N, Timofeeva OA, Dome JS, Perantoni AO. ELR+-CXC chemokines and their receptors in early metanephric development. J Am Soc Nephrol. 2007 Aug; 18(8):2359-70. PMID: 17634442.
      View in: PubMed
    73. Natrajan R, Williams RD, Grigoriadis A, Mackay A, Fenwick K, Ashworth A, Dome JS, Grundy PE, Pritchard-Jones K, Jones C. Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer. 2007 Jun; 46(6):607-15. PMID: 17370329.
      View in: PubMed
    74. Tabori U, Dome JS. Telomere biology of pediatric cancer. Cancer Invest. 2007 Apr-May; 25(3):197-208. PMID: 17530490.
      View in: PubMed
    75. Natrajan R, Warren W, Messahel B, Reis-Filho JS, Brundler MA, Dome JS, Grundy PE, Vujanic G, Pritchard-Jones K, Jones C. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours. J Clin Pathol. 2008 Jan; 61(1):95-102. PMID: 17369505.
      View in: PubMed
    76. Natrajan R, Little SE, Sodha N, Reis-Filho JS, Mackay A, Fenwick K, Ashworth A, Perlman EJ, Dome JS, Grundy PE, Pritchard-Jones K, Jones C. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. J Pathol. 2007 Jan; 211(1):52-9. PMID: 17103382.
      View in: PubMed
    77. Natrajan R, Little SE, Reis-Filho JS, Hing L, Messahel B, Grundy PE, Dome JS, Schneider T, Vujanic GM, Pritchard-Jones K, Jones C. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7284-93. PMID: 17189400.
      View in: PubMed
    78. Natrajan R, Reis-Filho JS, Little SE, Messahel B, Brundler MA, Dome JS, Grundy PE, Vujanic GM, Pritchard-Jones K, Jones C. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse. Cancer Res. 2006 Dec 01; 66(23):11148-55. PMID: 17145858.
      View in: PubMed
    79. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene. 2006 Dec 07; 25(58):7555-64. PMID: 16799645.
      View in: PubMed
    80. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May 20; 24(15):2352-8. PMID: 16710034.
      View in: PubMed
    81. Yamamoto M, Suzuki N, Hatakeyama N, Mizue N, Hori T, Kuroiwa Y, Hareyama M, Oda T, Kudoh T, Nui A, Matsuno T, Hirama T, Yokoyama S, Dome JS, Tsutsumi H. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report. J Pediatr Hematol Oncol. 2006 May; 28(5):286-9. PMID: 16772877.
      View in: PubMed
    82. Geller JI, Dome JS. Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma. Pediatr Blood Cancer. 2006 Apr; 46(4):527. PMID: 16365852.
      View in: PubMed
    83. Furman WL, Crews KR, Billups C, Wu J, Gajjar AJ, Daw NC, Patrick CC, Rodriguez-Galindo C, Stewart CF, Dome JS, Panetta JC, Houghton PJ, Santana VM. Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. J Clin Oncol. 2006 Feb 01; 24(4):563-70. PMID: 16446328.
      View in: PubMed
    84. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist. 2005 Nov-Dec; 10(10):815-26. PMID: 16314292.
      View in: PubMed
    85. Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PR, Perlman E, Beckwith JB, D'Angio GJ, Green DM. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005 Oct 20; 23(30):7641-5. PMID: 16234525.
      View in: PubMed
    86. Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol. 2005 Dec 20; 23(36):9138-45. PMID: 16172460.
      View in: PubMed
    87. Dome JS, Green DM, Cotton CA, Breslow NE, Perlman EJ, Miser J, Ritchey ML, Shamberger R, Thomas PR, Grundy PE. Treatment of anaplastic Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol. 2005 Jun; 23(16_suppl):8508. PMID: 27944564.
      View in: PubMed
    88. Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004 Oct 01; 101(7):1575-83. PMID: 15378495.
      View in: PubMed
    89. Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol. 2004 Sep 15; 22(18):3790-7. PMID: 15365076.
      View in: PubMed
    90. Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS. Disappearance of the telomere dysfunction-induced stress response in fully senescent cells. Cancer Res. 2004 Jun 01; 64(11):3748-52. PMID: 15172978.
      View in: PubMed
    91. Corey B, Yang CH, Wilimas JA, Davidoff A, Dome JS. Significance of pleural effusion at diagnosis of Wilms tumor. Pediatr Blood Cancer. 2004 Feb; 42(2):145-8. PMID: 14752878.
      View in: PubMed
    92. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ. Management of Wilms' tumour: current practice and future goals. Lancet Oncol. 2004 Jan; 5(1):37-46. PMID: 14700607.
      View in: PubMed
    93. Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003 Nov 15; 9(15):5442-53. PMID: 14654523.
      View in: PubMed
    94. Okamoto Y, Mathew S, Daw NC, Neel MD, McCarville MB, Dome JS, Hill DA. Giant cell tumor of bone with pulmonary metastases. Med Pediatr Oncol. 2003 Nov; 41(5):454-9. PMID: 14515387.
      View in: PubMed
    95. Hill DA, Shear TD, Liu T, Billups CA, Singh PK, Dome JS. Clinical and biologic significance of nuclear unrest in Wilms tumor. Cancer. 2003 May 01; 97(9):2318-26. PMID: 12712489.
      View in: PubMed
    96. Ehrlich M, Hopkins NE, Jiang G, Dome JS, Yu MC, Woods CB, Tomlinson GE, Chintagumpala M, Champagne M, Dillerg L, Parham DM, Sawyer J. Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet. 2003 Mar; 141(2):97-105. PMID: 12606126.
      View in: PubMed
    97. Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E, Campana D. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol. 2003 Mar; 120(5):846-9. PMID: 12614220.
      View in: PubMed
    98. Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, Parham D, Liang G, Malik K, Laird PW. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene. 2002 Sep 26; 21(43):6694-702. PMID: 12242669.
      View in: PubMed
    99. Loeb DM, Hill DA, Dome JS. Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. J Pediatr Hematol Oncol. 2002 Aug-Sep; 24(6):478-81. PMID: 12218597.
      View in: PubMed
    100. Muwakkit S, Antillon F, Valverde P, Jenkins JJ, Zaatari G, Dome JS. Simultaneous occurrence of Wilms tumor and rhabdomyosarcoma in two patients. Med Pediatr Oncol. 2002 Aug; 39(2):143-5. PMID: 12116068.
      View in: PubMed
    101. Wagner L, Hill DA, Fuller C, Pedrosa M, Bhakta M, Perry A, Dome JS. Treatment of metastatic rhabdoid tumor of the kidney. J Pediatr Hematol Oncol. 2002 Jun-Jul; 24(5):385-8. PMID: 12142788.
      View in: PubMed
    102. Rodríguez-Galindo C, Daw NC, Kaste SC, Meyer WH, Dome JS, Pappo AS, Rao BN, Pratt CB. Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide. J Pediatr Hematol Oncol. 2002 May; 24(4):250-5. PMID: 11972091.
      View in: PubMed
    103. Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol. 2002 Mar-Apr; 24(3):192-8. PMID: 11990305.
      View in: PubMed
    104. Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. Curr Opin Pediatr. 2002 Feb; 14(1):5-11. PMID: 11880727.
      View in: PubMed
    105. Gow KW, Dome JS, Iglesias J, Novick WM, Hoffer FA, Davidoff AM. Intraatrial and intracaval Wilms' tumor. J Pediatr Surg. 2001 Dec; 36(12):1869-71. PMID: 11733929.
      View in: PubMed
    106. Carey LA, Kim NW, Goodman S, Marks J, Henderson G, Umbricht CB, Dome JS, Dooley W, Amshey SR, Sukumar S. Telomerase activity and prognosis in primary breast cancers. J Clin Oncol. 1999 Oct; 17(10):3075-81. PMID: 10506602.
      View in: PubMed
    107. Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res. 1999 Sep 01; 59(17):4301-7. PMID: 10485476.
      View in: PubMed
    108. Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets. Curr Opin Oncol. 1999 Jan; 11(1):58-67. PMID: 9914880.
      View in: PubMed
    109. Carey LA, Hedican CA, Henderson GS, Umbricht CB, Dome JS, Varon D, Sukumar S. Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers. Clin Cancer Res. 1998 Feb; 4(2):435-40. PMID: 9516933.
      View in: PubMed
    110. Varon D, Jiang C, Hedican C, Dome JS, Umbricht CB, Carey LA, Thompson HJ, Sukumar S. Telomerase activity in the normal and neoplastic rat mammary gland. Cancer Res. 1997 Dec 15; 57(24):5605-9. PMID: 9407974.
      View in: PubMed
    111. Dome JS, Schwartz CL. Osteosarcoma. Cancer Treat Res. 1997; 92:215-51. PMID: 9494763.
      View in: PubMed
    Dome's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _